AUSTIN, Texas, May 12, 2025 /PRNewswire/ -- ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the "Company") with approximately 13.3% of the Company's outstanding shares, today released an...
Hence then, the article about adar1 capital management releases investor presentation outlining its rationale for withholding votes from directors dr mary ann gray and dr alpna seth was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ADAR1 Capital Management Releases Investor Presentation Outlining Its Rationale for Withholding Votes From Directors Dr. Mary Ann Gray and Dr. Alpna Seth )
Also on site :
- This 'Nostalgic' 1980s Calvin Klein Perfume Is Perfect for the Fall-to-Summer Transition and Now 75% Off
- Magnificent Seven Star, With Two Skills Named After Her, Built an Extraordinary Life After Olympic Gold
- Martha Stewart's 'Beautiful' Watercolor Floral Dish Towel Set Brings an 'Elegant Touch' to Any Kitchen